Effects of gonadotropin-releasing hormone agonist therapy on body mass index and height in girls with central precocious puberty.

Chonnam Medical Journal
Seung Jae LeeChan Jong Kim

Abstract

Treatment with gonadotropin-releasing hormone (GnRH) agonist is the treatment of choice for central precocious puberty (CPP). Many of the previous studies concerning the auxological effects of treatment with GnRH agonist in CPP have focused on final height. Much less attention has been paid to changes in body weight. However, concerns have been expressed that CPP may be associated with increased body mass index (BMI) both at initial presentation and during GnRH agonist treatment. We retrospectively reviewed the height and BMI of 38 girls with CPP. All patients were treated with GnRH agonist over 18 months. The height standard deviation score (SDS) for chronological age was significantly decreased during GnRH agonist treatment, whereas the height SDS for bone age was significantly increased. The predicted adult height was increased from 157.78±6.45 cm before treatment to 161.41±8.97 cm at 12 months after treatment. The BMI SDS for chronological age was significantly increased during treatment. The BMI SDS of normal-weight girls increased more than did the BMI SDS of overweight girls, but the increase was not significant. Preventive measures, such as increased physical activity, can be introduced to minimize possible alterations ...Continue Reading

References

Jun 1, 1969·Archives of Disease in Childhood·W A Marshall, J M Tanner
May 26, 1999·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·R P Troiano, K M Flegal
Aug 16, 2000·Current Opinion in Pediatrics·M C Lebrethon, J P Bourguignon
Jun 18, 2002·Hormone Research·Johan Karlberg
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Martina WeiseJeffrey Baron
Apr 10, 2004·Human Reproduction Update·Jean-Claude CarelJean Louis Chaussain
Apr 15, 2004·European Journal of Endocrinology·Teresa ArrigoFortunato Lombardo
Sep 10, 2005·Best Practice & Research. Clinical Endocrinology & Metabolism·David B DungerKen K Ong
Apr 6, 2006·JAMA : the Journal of the American Medical Association·Cynthia L OgdenKatherine M Flegal
Jan 16, 2007·Journal of Pediatric Endocrinology & Metabolism : JPEM·A L AguiarL Adan
Dec 17, 2008·European Journal of Endocrinology·D Mul, I A Hughes
Feb 25, 2011·The Journal of Clinical Endocrinology and Metabolism·Signe Sloth MogensenAnders Juul
Oct 22, 2011·The Korean journal of laboratory medicine·Han Kyul KimChan Jong Kim

❮ Previous
Next ❯

Citations

Sep 25, 2015·International Journal of Endocrinology and Metabolism·Kobra Shiasi Arani, Fatemeh Heidari
Aug 9, 2016·International Journal of Pediatric Endocrinology·A J ArcariM E Escobar
Feb 6, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jessie N Zurita-CruzAdriana Poblano-Alcalá
Dec 6, 2019·Journal of Pediatric Endocrinology & Metabolism : JPEM·Dogus VuralliNurgun Kandemir
Sep 20, 2017·Journal of Women's Health·Lorenzo Rossi, Olivia Pagani
Aug 2, 2020·The Journal of Clinical Endocrinology and Metabolism·Karen O KleinNelly Mauras
Dec 17, 2020·Journal of the Endocrine Society·Lillian SauVarykina G Thackray
Mar 22, 2021·European Journal of Pediatrics·Amanda Veiga CheuicheSandra Pinho Silveiro

❮ Previous
Next ❯

Software Mentioned

SPSS
Statistical Package for Social Sciences

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.